CAS 863029-99-6

Fórmula: C30H32ClN7OS

InChI: InChI=1S/C30H32ClN7OS/c1-36-14-9-33-30(36)40-28-6-5-21(15-24(28)31)35-29-20(18-32)19-34-25-17-26(27(39-2)16-23(25)29)38-12-7-22(8-13-38)37-10-3-4-11-37/h5-6,9,14-17,19,22H,3-4,7-8,10-13H2,1-2H3,(H,34,35)

Clave InChI: CVAKNHIXTWLGJO-UHFFFAOYSA-N

SMILES: CN1C=CN=C1SC2=C(C=C(C=C2)NC3=C(C=NC4=CC(=C(C=C43)OC)N5CCC(CC5)N6CCCC6)C#N)Cl

4-[[3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl]amino]-6-methoxy-7-[4-(1-pyrrolidinyl)-1-piperidinyl]-3-quinolinecarbonitrile

CAS: 863029-99-6

4-[[3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl]amino]-6-methoxy-7-[4-(1-pyrrolidinyl)-1-piperidinyl]-3-quinolinecarbonitrile

Fórmula: C₃₀H₃₂ClN₇OS

Pureza: 95%

Peso molecular: 574.14

Ref: 54-OR1121175

4-[[3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl]amino]-6-methoxy-7-[4-(1-pyrrolidinyl)-1-piperidinyl]-3-quinolinecarbonitrile

CAS: 863029-99-6

Fórmula: C₃₀H₃₂ClN₇OS

Pureza: 95%

Forma y color: Solid

Peso molecular: 574.1394

Ref: IN-DA01ENVL

Balamapimod

CAS: 863029-99-6

Balamapimod is a linker that can be used in the diagnosis and treatment of cancer. It is a prodrug that undergoes hydrolysis to produce an active drug, which binds to the amino acid sequence of tumor cells and disrupts the function of these cells. The drug is also able to crosslink with other molecules, such as proteins and nucleic acids, which are involved in the development of cancer. Balamapimod has been shown to inhibit the growth of tumor cells by blocking the synthesis of DNA and RNA. This drug has been shown to have no toxicity on healthy cells or tissues.

Fórmula: C₃₀H₃₂ClN₇OS

Pureza: Min. 95%

Peso molecular: 574.1 g/mol

Ref: 3D-NJB02999

Balamapimod

CAS: 863029-99-6

Balamapimod is a reversible inhibitor of Ras/Raf/MEK. It also has a potential anti-tumor activity.

Fórmula: C₃₀H₃₂ClN₇OS

Pureza: 99.84%

Forma y color: White Solid

Peso molecular: 574.139

Ref: TM-T16100